A Phase III, Randomized, Double-blind Trial Comparing Trastuzumab Plus Chemotherapy and Pembrolizumab With Trastuzumab Plus Chemotherapy and Placebo as Firstline Treatment in Participants With HER2 Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (KEYNOTE 811)

Project: Research

Project Details

StatusActive
Effective start/end date6/02/20 → 5/02/25
View all
View less

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • GE junction cancer